Highlights Bausch Health Companies Inc.

Equities

BHC

CA0717341071

Market Closed - Nyse Other stock markets 21:00:01 08/05/2024 BST			5-day change	1st Jan Change
7.03 ^USD	-5.13%		-19.66%	-12.34%

05-03	RBC Lowers Bausch Health Target to US$10, Maintains Sector Perform	MT
05-02	Bausch Health Shares Fall Following Q1 Results	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Lowers Bausch Health Target to US$10, Maintains Sector Perform	05-03	MT
Bausch Health Shares Fall Following Q1 Results	05-02	MT
Bausch Health Q1 Net Loss Narrows on Higher Revenue, Confirms 2024 Revenue Guidance	05-02	MT
Bausch Health Brief: Reaffirmed full-year Revenue and Adjusted EBITDA (non-GAAP) guidance	05-02	MT
Bausch Health Brief: Q1 revenues of US$2.15 billion, up 11% on a Reported and 8% on an Organic basis	05-02	MT
Bausch Health Companies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year	05-01	MT
Bausch + Lomb Brief: Raising Full-Year 2024 Constant Currency Revenue Growth Guidance	05-01	MT
Bausch + Lomb Brief: Q1 Adjusted EBITDA (non-GAAP) of US$180 Million	05-01	MT
Bausch + Lomb Brief: Q1 Revenue of US$1.099 Billion; GAAP Net Loss Attributable of $167 Million	05-01	MT
Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes	04-25	MT
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes	04-25	MT
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	04-12	MT
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	04-12	MT
Bausch wins US appeal to block Alvogen generic of diarrhea drug	04-11	RE
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan	04-11	CI
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	04-08	RE
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	04-08	MT
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling	04-05	MT
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for Uceris Aerosol Foam	04-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bausch Health Companies Inc.

Equities

BHC

CA0717341071

Highlights

Filters